Stuart L. Dombey
Fondateur chez QuatRx Pharmaceuticals Co.
Profil
Stuart L.
Dombey is the founder and the Chief Scientific Officer of QuatRx Pharmaceuticals Co., which was founded in 2000.
He held the position of Vice President-Regulatory Affairs at Parke-Davis & Co. Ltd.
from 1990 to 2012.
He also served as Vice President-Regulatory Affairs at Squibb Corp.
from 2009 to 2012.
Additionally, Dr. Dombey worked as a Medical Advisor at Hoechst UK Ltd.
Dr. Dombey graduated from The University of Liverpool in 1971.
Postes actifs de Stuart L. Dombey
| Sociétés | Poste | Début |
|---|---|---|
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Fondateur | 20/11/2000 |
Anciens postes connus de Stuart L. Dombey
| Sociétés | Poste | Fin |
|---|---|---|
| Squibb Corp. | Conseiller Juridique Général | - |
| Hoechst UK Ltd. | Corporate Officer/Principal | - |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Conseiller Juridique Général | - |
Formation de Stuart L. Dombey
| The University of Liverpool | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Health Technology |
| Squibb Corp. | Health Technology |
| Hoechst UK Ltd. |
